Research advances of factors and mechanisms for therapeutic efficacy of rituximab for primary membranous nephropathy

Primary membranous nephropathy (PMN) is a kidney-specific autoimmune disease mediated by autoantibodies. Although rituximab (RTX) has been widely applied as a first-line treatment for PMN, 20%-40% patients are non-responsive to RTX. High disease activity, severe renal lesions and low RTX bioavailabi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Yu-ting Liu (Auteur), Yue Wang (Auteur)
Formaat: Boek
Gepubliceerd in: Editorial Department of Journal of Clinical Nephrology, 2024-09-01T00:00:00Z.
Onderwerpen:
Online toegang:Connect to this object online.
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Internet

Connect to this object online.

3rd Floor Main Library

Exemplaargegevens van 3rd Floor Main Library
Plaatsingsnummer: A1234.567
Kopie 1 Beschikbaar